These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8669679)

  • 1. Chlorocresol, an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel.
    Tegazzin V; Scutari E; Treves S; Zorzato F
    Anesthesiology; 1996 Jun; 84(6):1380-5. PubMed ID: 8669679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles.
    Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Schulte am Esch J
    Anesth Analg; 1996 Jun; 82(6):1230-6. PubMed ID: 8638796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor.
    Herrmann-Frank A; Richter M; Sarközi S; Mohr U; Lehmann-Horn F
    Biochim Biophys Acta; 1996 Feb; 1289(1):31-40. PubMed ID: 8605229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of propofol on Ca2+ regulation by malignant hyperthermia-susceptible muscle membranes.
    Fruen BR; Mickelson JR; Roghair TJ; Litterer LA; Louis CF
    Anesthesiology; 1995 May; 82(5):1274-82. PubMed ID: 7741303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-chloro-m-cresol cannot detect malignant hyperthermia equivocal cells in an alternative minimally invasive diagnostic test of malignant hyperthermia susceptibility.
    Weigl LG; Ludwig-Papst C; Kress HG
    Anesth Analg; 2004 Jul; 99(1):103-107. PubMed ID: 15281512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.
    Steinfath M; Singh S; Scholz J; Becker K; Lenzen C; Wappler F; Köchling A; Roewer N; Schulte am Esch J
    J Mol Med (Berl); 1995 Jan; 73(1):35-40. PubMed ID: 7633940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+ ].
    López JR; Contreras J; Linares N; Allen PD
    Anesthesiology; 2000 Jun; 92(6):1799-806. PubMed ID: 10839932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
    Sei Y; Brandom BW; Bina S; Hosoi E; Gallagher KL; Wyre HW; Pudimat PA; Holman SJ; Venzon DJ; Daly JW; Muldoon S
    Anesthesiology; 2002 Nov; 97(5):1052-8. PubMed ID: 12411786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
    Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K
    Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release.
    Zorzato F; Scutari E; Tegazzin V; Clementi E; Treves S
    Mol Pharmacol; 1993 Dec; 44(6):1192-201. PubMed ID: 8264556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
    Yang T; Ta TA; Pessah IN; Allen PD
    J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.
    Nelson TE; Lin M; Zapata-Sudo G; Sudo RT
    Anesthesiology; 1996 Jun; 84(6):1368-79. PubMed ID: 8669678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of 4-chloro-m-cresol in heparin formulas on malignant hyperthermia: in vitro and in vivo.
    Anetseder M; Ritter L; Horbaschek H; Hartung E; Roewer N
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):338-42. PubMed ID: 10714851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermic skeletal muscle.
    Fill M; Stefani E; Nelson TE
    Biophys J; 1991 May; 59(5):1085-90. PubMed ID: 1651122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle.
    Foster PS; Denborough MA
    Int J Biochem; 1993 Apr; 25(4):495-504. PubMed ID: 7682190
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.